Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19 is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UL1TR001422-04
Northwestern University Clinical and Translational Science Institute (NUCATS)
Fields of Study
Keywords
Sustainable Development Goals